J Neurol (2011) 258:795–803 3. Welch KM, Cao Y, Nagesh V (2000) Magnetic resonance assessment of acute and chronic stroke. Prog Cardiovasc Dis 43:113–134 4. Scheltens P, Barkhof F, Fazekas F (2003) White-matter changes on MRI as surrogate marker. Int Psychogeriatr 15(Suppl 1):261–265 5. Sorbera LA, Serradell N, Bolos J et al (2006) Terutroban sodium: prostanoid TP receptor antagonist, antithrombotic agent, anti- atherosclerotic agent. Drugs Future 31:867–873 6. Bousser MG, Amarenco P, Chamorro A et al (2009) Rationale and design of a randomized, double-blind, parallel-group study of terutroban 30 mg/day versus aspirin 100 mg/day in stroke patients: the Prevention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PER- FORM) study. Cerebrovasc Dis 27(5):509–518 7. Bousser MG, Amarenco P, Chamorro A et al (2009) The Pre- vention of cerebrovascular and cardiovascular Events of ischemic origin with teRutroban in patients with a history oF ischemic strOke or tRansient ischeMic attack (PERFORM) study: baseline characteristics of the population. Cerebrovasc Dis 27(6):608–613 8. Chen CC, Wan YL, Wai YY et al (2004) Quality assurance of clinical MRI scanners using ACR MRI phantom: preliminary results. J Digit Imaging 17(4):279–284 9. Jack CR Jr, Bernstein MA, Fox NC et al (2008) The Alzheimer’s disease neuroimaging initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685–691 10. Brant-Zawadzki M, Atkinson D, Detrick M et al (1996) Fluid- attenuated inversion recovery (FLAIR) for assessment of cerebral infarction. Initial clinical experience in 50 patients. Stroke 27(7):1187–1191 803 11. Barkhof F, Scheltens P (2002) Imaging of white matter lesions. Cerebrovasc Dis 13(2):21–30 12. Muir KW, Buchan A, von Kummer R et al (2006) Imaging of acute stroke. Lancet Neurol 5(9):755–768 Review 13. Vemuri BC, Ye J, Chen Y et al (2003) Image registration via level-set motion: applications to atlas-based segmentation. Med Image Anal 7(1):1–20 14. Freeborough PA, Fox NC (1997) The boundary shift integral: an accurate and robust measure of cerebral volume changes from registered repeat MRI. IEEE Trans Med Imaging 16(5):623–629 15. Boyes RG, Rueckert D, Aljabar P et al (2006) Cerebral atrophy measurements using Jacobian integration: comparison with the boundary shift integral. Neuroimage 32(1):159–169 16. Anderson VM, Fox NC, Miller DH (2006) Magnetic resonance imaging measures of brain atrophy in multiple sclerosis. J Magn Reson Imaging 23(5):605–618 17. Cordonnier C (2008) Brain microbleeds. Neurol 164(10):805– 808 18. Imaizumi T, Honma T, Horita Y et al (2005) Dotlike hemosiderin spots are associated with past hemorrhagic strokes in patients with lacunar infarcts. J Neuroimaging 15(2):157–163 19. Jones DK, Lythgoe D, Horsﬁeld MA et al (1999) Characteriza- tion of white matter damage in ischemic leukoaraiosis with dif- fusion tensor MRI. Stroke 30(2):393–397 20. Sullivan EV, Pfefferbaum A (2006) Diffusion tensor imaging and aging. Neurosci Biobehav Rev 30(6):749–761 21. Hagmann P, Jonasson L, Maeder P et al (2006) Understanding diffusion MR imaging techniques: from scalar diffusion-weighted imaging to diffusion tensor imaging and beyond. Radiographics 26(1):S205–S223 123